Phosphorylase
抑制剂选择性比较
Phosphorylase产品
| 目录号 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S2717 |
CP-91149CP-91149在有葡萄糖存在时，选择性抑制糖原磷酸化酶，IC50为0.13 μM，在无葡萄糖存在时，作用效果低5到10倍。 |
C, experimental design illustrating the time points in which PYGL inhibitor CP-91149 (GPi) and 2DG were added to the groups depicted in D to J. D, representative images of cell invasion through the Boyden chamber from control, 2DG and recovery GBM1 treated with GPi or DMSO. E to G, comparison of the invasive capacity of EV or shG6PC in the presence or absence of GPi. |
|
| S6510 |
Iso-H7 dihydrochlorideIso-H7 dihydrochloride是磷酸激酶C抑制剂。 |
||
| S3731 |
Tipiracil hydrochlorideTipiracil是一种 thymidine phosphorylase的抑制剂，该酶可将三氟吡啶降解为三氟胸苷。它与三氟吡啶的组合可增加三氟吡啶的生物利用度。 |
||
| S2045 |
DoxifluridineDoxifluridine (5'-DFUR, AMC 0101) 是一种胸苷磷酸化酶激活剂，作用于PC9-DPE2细胞，IC50为0.62 μM。 |
| 目录号 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S2717 |
CP-91149CP-91149在有葡萄糖存在时，选择性抑制糖原磷酸化酶，IC50为0.13 μM，在无葡萄糖存在时，作用效果低5到10倍。 |
C, experimental design illustrating the time points in which PYGL inhibitor CP-91149 (GPi) and 2DG were added to the groups depicted in D to J. D, representative images of cell invasion through the Boyden chamber from control, 2DG and recovery GBM1 treated with GPi or DMSO. E to G, comparison of the invasive capacity of EV or shG6PC in the presence or absence of GPi. |
|
| S6510 |
Iso-H7 dihydrochlorideIso-H7 dihydrochloride是磷酸激酶C抑制剂。 |
||
| S3731 |
Tipiracil hydrochlorideTipiracil是一种 thymidine phosphorylase的抑制剂，该酶可将三氟吡啶降解为三氟胸苷。它与三氟吡啶的组合可增加三氟吡啶的生物利用度。 |
| 目录号 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S2045 |
DoxifluridineDoxifluridine (5'-DFUR, AMC 0101) 是一种胸苷磷酸化酶激活剂，作用于PC9-DPE2细胞，IC50为0.62 μM。 |
沪公网安备 31011502012800号